Have your own idea? Try our Stock Screener
Argentinian (MERVAL) Pharma Industry Analysis
UpdatedDec 26, 2025
DataAggregated Company Financials
Companies2
- 7D-4.8%
- 3M91.7%
- 1Y19.6%
- YTDn/a
Over the last 7 days, the Pharma industry has dropped 4.8%, driven by a pullback from Laboratorios RichmondC.I.F of 5.5%. Meanwhile, Instituto Rosenbusch actually outperformed within the industry, gaining 6.2% in the last week. Over the past 12 months, the industry was up 20%.
Industry Valuation and Performance
Has the Argentinian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Dec 2025 | AR$170.5b | AR$108.5b | -AR$8,970,776,885.00 | n/a | -19x | 1.6x |
| Sun, 23 Nov 2025 | AR$156.9b | AR$108.5b | -AR$8,970,776,885.00 | n/a | -17.5x | 1.4x |
| Tue, 21 Oct 2025 | AR$96.2b | AR$103.2b | AR$8.2b | 7.9x | 11.7x | 0.9x |
| Thu, 18 Sep 2025 | AR$94.1b | AR$104.5b | AR$9.0b | 7.4x | 10.4x | 0.9x |
| Sat, 16 Aug 2025 | AR$112.1b | AR$104.5b | AR$9.0b | 9x | 12.4x | 1.1x |
| Mon, 14 Jul 2025 | AR$127.0b | AR$102.7b | AR$16.3b | 6.2x | 7.8x | 1.2x |
| Wed, 11 Jun 2025 | AR$133.0b | AR$104.7b | AR$17.4b | 6.2x | 7.7x | 1.3x |
| Fri, 09 May 2025 | AR$117.5b | AR$100.1b | AR$22.4b | 4.8x | 5.2x | 1.2x |
| Sun, 06 Apr 2025 | AR$128.1b | AR$97.1b | AR$23.7b | 5.2x | 5.4x | 1.3x |
| Tue, 04 Mar 2025 | AR$140.0b | AR$42.6b | AR$18.2b | 6.3x | 7.7x | 3.3x |
| Thu, 30 Jan 2025 | AR$135.1b | AR$42.6b | AR$18.2b | 6.2x | 7.4x | 3.2x |
| Sat, 28 Dec 2024 | AR$147.4b | AR$42.6b | AR$18.2b | 6.6x | 8.1x | 3.5x |
| Mon, 25 Nov 2024 | AR$155.2b | AR$42.6b | AR$18.2b | 6.9x | 8.5x | 3.6x |
| Wed, 23 Oct 2024 | AR$83.0b | AR$40.7b | AR$4.6b | 14.3x | 18.2x | 2x |
| Fri, 20 Sep 2024 | AR$78.8b | AR$40.7b | AR$4.6b | 12.9x | 17.3x | 1.9x |
| Sun, 18 Aug 2024 | AR$85.6b | AR$52.7b | AR$2.3b | 34.4x | 37.9x | 1.6x |
| Tue, 16 Jul 2024 | AR$84.6b | AR$41.1b | -AR$3,264,658,797.00 | 4.6x | -25.9x | 2.1x |
| Thu, 13 Jun 2024 | AR$85.0b | AR$41.1b | -AR$3,264,658,797.00 | 4.5x | -26x | 2.1x |
| Sat, 11 May 2024 | AR$77.7b | AR$43.6b | -AR$10,287,966,966.00 | 9.2x | -7.5x | 1.8x |
| Mon, 08 Apr 2024 | AR$77.8b | AR$9.6b | -AR$4,702,241,388.00 | 58.1x | -16.5x | 8.1x |
| Wed, 06 Mar 2024 | AR$70.7b | AR$9.6b | -AR$4,702,241,388.00 | 50.6x | -15x | 7.3x |
| Fri, 02 Feb 2024 | AR$97.5b | AR$10.3b | -AR$4,704,193,685.00 | 56.8x | -20.7x | 9.4x |
| Sun, 31 Dec 2023 | AR$59.1b | AR$10.3b | -AR$4,704,193,685.00 | 33.6x | -12.6x | 5.7x |
| Tue, 28 Nov 2023 | AR$63.4b | AR$19.4b | -AR$4,675,725,481.00 | n/a | -13.6x | 3.3x |
| Thu, 26 Oct 2023 | AR$55.5b | AR$13.0b | -AR$2,496,856,221.00 | n/a | -22.2x | 4.3x |
| Sat, 23 Sep 2023 | AR$43.0b | AR$13.0b | -AR$2,496,856,221.00 | n/a | -17.2x | 3.3x |
| Mon, 21 Aug 2023 | AR$49.0b | AR$18.8b | -AR$150,001,147.00 | 15.4x | -326.6x | 2.6x |
| Wed, 19 Jul 2023 | AR$44.2b | AR$18.8b | -AR$150,001,147.00 | 13.2x | -294.4x | 2.3x |
| Fri, 16 Jun 2023 | AR$42.0b | AR$19.1b | AR$209.1m | 136.4x | 200.8x | 2.2x |
| Sun, 14 May 2023 | AR$33.4b | AR$19.1b | AR$209.1m | 107.2x | 159.8x | 1.7x |
| Tue, 11 Apr 2023 | AR$32.0b | AR$19.1b | AR$209.1m | 102.6x | 153.2x | 1.7x |
| Thu, 09 Mar 2023 | AR$30.5b | AR$13.7b | AR$1.5b | 16.7x | 19.7x | 2.2x |
| Sat, 04 Feb 2023 | AR$32.3b | AR$13.7b | AR$1.5b | 17.4x | 20.9x | 2.4x |
| Mon, 02 Jan 2023 | AR$32.0b | AR$13.8b | AR$1.5b | 20.9x | 21.3x | 2.3x |
Price to Earnings Ratio
21.3x
Current Industry PE
- There are only 2 companies in the Argentinean Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 99% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Argentinian Pharma compare with similar industries?
| AR Market | -0.53% | |
| Healthcare | -4.84% | |
| Pharma | -4.84% | |
| Pharma | -4.84% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ROSE Instituto Rosenbusch | AR$249.50 | 6.2% +AR$617.5m | 100.0% | PS2.1x |